Numinus Wellness Inc. Announces First Quarter Fiscal 2025 ResultsAll financial results are reported in Canadian dollars unless otherwise stated.August 08, 2025 5:00 PM EDT | Source: Numinus Wellness Inc.Vancouver, British Columbia--(Newsfile Corp. - August 8, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted t ...

VANCOUVER, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, will release its financial results for the three and six months ended June 30, 2025 (“Q2 2025”) before market open on Monday, August 18, 2025. The Company will host a conference call to discuss Q2 2025 results on Monday, August 18, 2025. Conference call de ...

PARSIPPANY, N.J., Aug. 8, 2025 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the 2025 Citi Natural Resources Conference on June August 11-13, 2025.Any company presentation materials will be made available on the Investor Relations section of the PBF Energy website at www.pbfenergy.com.About PBF Energy Inc.PBF Energy Inc. (NYSE:PBF) is one of the largest independent refiners in North America, operating, through its subsidiaries, oil refiner ...

Core Points - Aurora Cannabis Inc. held its Annual General and Special Meeting of Shareholders on August 8, 2025, with 17,736,521 common shares represented, accounting for 31.53% of the total issued shares [1] - The election results for the Board of Directors showed that all nominees, except for Theresa Firestone, were elected [2] - Following the meeting, Theresa Firestone resigned from the Board effective August 31, 2025, and Michael Singer was appointed as the new Lead Independent Director and Chair of the Human Resources and Compensation Committee [3][4] - Shareholders approved the appointment of Ernst & Young LLP as auditors and amendments to the Company's RSU Plan, PSU Plan, and Share Option Plan, but the advisory vote on executive compensation did not pass [5] Voting Results - Miguel Martin received 5,513,929 votes for his position, while Theresa Firestone received only 2,620,830 votes for her position, leading to her resignation [2][3] - The voting results indicate a strong preference for the other board nominees, with the highest votes for Michael Singer at 5,194,307 [2] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across multiple regions including Canada, Europe, Australia, and New Zealand [7] - The company offers a diverse portfolio of brands in both adult-use and medical cannabis markets, emphasizing high-quality products and innovation [7][8]

Core Insights - Stonegate Capital Partners has initiated coverage on Nu Skin Enterprises Inc. (NUS) [1] - NUS reported revenue of $386.1 million, adjusted net income of $21.1 million, and adjusted EPS of $0.43, exceeding guidance [1] - The Rhyz Manufacturing segment experienced a 17% year-over-year revenue growth [1] - Gross margin for the quarter was 68.8%, reflecting a quarter-over-quarter expansion of 106 basis points from Q1 2025 [1] - Adjusted net income grew by 103.5% year-over-year, driven by revenue growth and operational optimization [1] - The company is positioned for a solid second quarter of 2025 with continued net income margin expansion [1] Financial Performance - Revenue was at the high end of the guidance range, which was between $355.0 million and $390.0 million [1] - Adjusted EPS of $0.43 significantly outpaced the guidance range of $0.20 to $0.30 [1] - Latin America revenue increased by 107% year-over-year [7] - The company achieved a net cash position ahead of schedule [7] Strategic Developments - The expansion in India and the launch of the Prysm iO device are on track [7]

GoDaddy beat earnings estimates but the stock still tumbled. Here's why investors weren't impressed.Shares of GoDaddy (GDDY -11.25%) fell as much as 11.5% on Friday, following a solid earnings report with modest guidance. By 3:30 p.m. ET, the domain name registrar's shares had dropped by 11%. GoDaddy's modest earnings beatGoDaddy's second-quarter sales rose by 8% year over year, stopping at $1.21 billion. Earnings jumped from $1.01 to $1.41 per diluted share. The analyst consensus pointed to earnings near $ ...

Group 1 - The final agenda and proposals for the shareholders' meeting of Fly Play hf. are set to take place on August 15 [1][2]

Group 1 - Assembly Biosciences, Inc. (NASDAQ: ASMB) released results from its phase 1b study of ABI-5366, a long-acting helicase-primase inhibitor for treating recurrent genital herpes [2] - The study results are significant for the treatment of patients suffering from recurrent genital herpes, indicating potential advancements in the pharmaceutical sector [2] Group 2 - The Biotech Analysis Central service offers a comprehensive analysis of various pharmaceutical companies, including a library of over 600 articles and a model portfolio of small and mid-cap stocks [2]

Core Insights - The upcoming week will feature significant economic indicators including Consumer Price Index (CPI), Producer Price Index (PPI), retail sales data, and consumer sentiment metrics [1][2] Economic Indicators - CPI and PPI are critical measures that will provide insights into inflation trends and pricing pressures within the economy [1][2] - Retail sales figures will be closely monitored as they reflect consumer spending habits, which are vital for economic growth [1][2] - Consumer sentiment data will offer an understanding of consumer confidence, influencing spending and investment decisions [1][2]

Group 1: Company Performance - Airbnb's stock experienced a decline of 9.1% following the release of its second-quarter earnings report, despite beating expectations with an EPS of $1.03 and revenue of $3.10 billion, reflecting year-over-year gains of 19% and 12% respectively [1][2] - The company's Q3 revenue guidance of $4.02 to $4.1 billion indicates approximately 8% year-over-year growth, which is a deceleration from the 12% growth reported in Q2 [2] - CEO Brian Chesky expressed dissatisfaction with the company's slow growth and emphasized the need for acceleration, although no specific initiatives were outlined during the earnings call [4][5] Group 2: Market Sentiment and Analyst Ratings - The consensus price target for Airbnb's stock is $143.07, suggesting about 20% upside potential, but several analysts have lowered their price targets since the earnings report [9] - The stock is currently rated as a Hold among analysts, with some suggesting that it may not be a favorable investment at this time due to slowing growth and challenges in innovation [7][13] - A new share repurchase program of up to $6 billion was announced, which is generally seen as positive for shareholders, yet the stock is valued at 30x forward earnings, indicating a mature company facing growth challenges [8] Group 3: Economic Context - Recent data from Bank of America indicates a decline in consumer spending on services, including travel, which may negatively impact companies like Airbnb [3][4] - The July Jobs report raised concerns about the strength of the U.S. consumer, leading to skepticism among investors regarding the outlook for consumer discretionary stocks [3]